SC 13D

Company

BioLineRx Ltd.

Filed

October 26, 2023

Accession Number

0001178913-23-003401

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →